Evidence map›Paper›PMID 42401827›Full record

ArticleBMC genomic data2026

Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson's disease tissue.

Indra Roy, Michael Fiorini, Rhalena A Thomas, Georgina Jimenez Ambriz, Sali Farhan, Valerio E C Piscopo, Thomas M Durcan

Abstract read
In one paragraph

Article in BMC genomic data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Indra RoyThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada.
Michael FioriniDepartment of Human Genetics, McGill University, Montreal, Canada.
Rhalena A ThomasThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada.
Georgina Jimenez AmbrizThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada.
Sali FarhanThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada.
Valerio E C PiscopoThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada.
Thomas M DurcanThe Neuro's Early Drug Discovery Unit (EDDU), McGill University, Montreal, Canada. thomas.durcan@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is a neurodegenerative disease marked by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and formation of misfolded protein aggregates. A growing body of research has implicated glial cell dysfunction in PD etiology, including the concentration of activated glial cells around protein aggregates in post-mortem tissue. A disruption in the balance of pro- and anti-inflammatory immune response functions of microglia and astrocytes is believed to contribute towards neuronal degeneration as the disease progresses. However, the molecular mechanisms remain unclear. To shed light on the role of microglia and astrocytes in PD, this study analyzes three public single nuclear RNA sequencing datasets of the SNpc from patient and control post-mortem brains to identify altered molecular pathways in PD.

resultsBoth astrocytes and microglia show significant upregulation of heat shock binding and misfolded protein response pathways, likely reflecting a response to accumulating protein aggregates. Additionally, both cell types show decreased expression of genes associated with receptor functions; for microglia this included cytokine receptor genes such as IL21R, IL4R, and IFI44L. Genes associated with resting state microglia and non-inflammatory reactive state microglia were downregulated in PD microglia, including P2RY13, RSAD2, CSF2RA, CSF3R, and CX3CR1. Concurrently, astrocytes and microglia both show decreased expression of genes associated with neurotransmitter receptor functions that include glutamate and other ion channel receptors, suggesting a loss of neuron-glia communication in later disease stages.

conclusionsTaken together, our findings imply that astrocytes and microglia respond to protein misfolding pathology in PD by upregulating chaperone protein folding functions. Additionally, the profile of upregulated functions implies that both cell types are under increased energetic demand. The downregulation of neurotransmitter and channel receptor functions in both cell types indicates that neuron-glia communication and other supportive functions may be lost in favour of autophagic, protein-clearance mechanisms in PD microglia and astrocytes.

Indexed as

AstrocytesMicrogliaParkinson DiseaseHumansSequence Analysis, RNAAstrocytesDifferential gene expression (DGE)Functional pathway analysisGene ontology (GO) molecular functionsGlial reactivityMicrogliaParkinson’s diseaseSingle-nuclear RNA sequencing

Identifiers

PMID42401827
PMCPMC13625337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.